| 100.01 Outcomes of Primary Percutaneous Coronary Intervention for STEMI With Versus Without SCAD A Chaturvedi, HM Garcia-Garcia, M Cellamare, P Chandrika, K Chitturi, ... Cardiovascular Interventions 17 (4_Supplement), S1-S1, 2024 | | 2024 |
| 100.06 Racial Differences in Outcomes of Primary Percutaneous Coronary Intervention for SCAD-Related STEMI A Chaturvedi, HM Garcia-Garcia, M Cellamare, P Chandrika, K Chitturi, ... Cardiovascular Interventions 17 (4_Supplement), S2-S3, 2024 | | 2024 |
| 100.59 High-Risk Percutaneous Coronary Intervention With or Without Prophylactic Mechanical Circulatory Support: Will Impella Show Superiority in the PROTECT IV Randomized Trial? KR Chitturi, C Zhang, D Haberman, A Chaturvedi, W Abusnina, L Lupu, ... Cardiovascular Interventions 17 (4_Supplement), S16-S17, 2024 | | 2024 |
| 100.77 Comparison of Surgical Cut-Down (5.0/5.5) Versus Percutaneously (2.5/CP) Inserted Impella for Post-Myocardial Infarction Cardiogenic Shock: A Systematic Review and … D Haberman, WA Abusnina, L Lupu, A Chaturvedi, KR Chitturi, ... Cardiovascular Interventions 17 (4_Supplement), S24-S24, 2024 | | 2024 |
| 100.88 Long-Term Clinical Outcomes of Bioabsorbable Versus Durable Polymer-Coated Everolimus-Eluting Stents in Real World: A Single-Center Post-Marketing Study W Abusnina, B Case, K Chitturi, A Chaturvedi, V Sawant, C Zhang, ... Cardiovascular Interventions 17 (4_Supplement), S28-S28, 2024 | | 2024 |
| 300.28 Percutaneous Endovascular Approach to the Management of Vascular Closure Device-Related Occlusive Complication D Haberman, L Lupu, KR Chitturi, E Czulada, A Chaturvedi, WA Abusnina, ... Cardiovascular Interventions 17 (4_Supplement), S40-S41, 2024 | | 2024 |
| 400.18 Exploring the Interplay Between Coronary Microvascular Dysfunction and Mental Health I Merdler, S Rahman, M Cellamare, KR Chitturi, A Chaturvedi, VS Sawant, ... Cardiovascular Interventions 17 (4_Supplement), S47-S47, 2024 | | 2024 |
| 400.23 Coronary Microvascular Dysfunction and Inflammation: Insights from the Coronary Microvascular Disease Registry I Merdler, BC Case, J Li, R Wallace, KR Chitturi, A Chaturvedi, C Zhang, ... Cardiovascular Interventions 17 (4_Supplement), S48-S49, 2024 | | 2024 |
| 500.24 Sex Differences in In-Hospital Outcomes After Complex and High-Risk, but Indicated, Percutaneous Coronary Intervention Without Prophylactic Impella Mechanical … KR Chitturi, C Zhang, A Chaturvedi, W Abusnina, D Haberman, L Lupu, ... Cardiovascular Interventions 17 (4_Supplement), S55-S55, 2024 | | 2024 |
| 800.5 Trends in Outcomes of Multi-transcatheter Strategy for the Treatment of Combined Aortic Stenosis and Mitral Regurgitation L Lupu, I Ben-Dor, D Haberman, K Chitturi, A Chaturvedi, W Abusnina, ... Cardiovascular Interventions 17 (4_Supplement), S75-S75, 2024 | | 2024 |
| AN ECHOGENIC MASS ON A BIOPROSTHETIC MITRAL VALVE KR Chitturi, S Kumar, M Khan, D Chen, C Goodner, S Cullum, ... Journal of the American College of Cardiology 75 (11_Supplement_1), 2953-2953, 2020 | | 2020 |
| Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity R Araujo-Gutierrez, KR Chitturi, J Xu, Y Wang, E Kinder, A Senapati, ... Cardio-Oncology 7, 1-8, 2021 | 25 | 2021 |
| Baseline Global Longitudinal Strain Predictive of Anthracycline-Induced Cardiotoxicity. Cardiooncology. 2021; 7 (1): 4. doi: 10.1186/s40959-021-00090-2.» R Araujo-Gutierrez, KR Chitturi, J Xu, Y Wang, E Kinder, A Senapati | 3 | |
| Bioprosthetic Aortic Valve Thrombosis: Definitions, Clinical Impact, and Management: A State-of-the-Art Review KR Chitturi, AI Aladin, R Braun, AK Al-Qaraghuli, A Banerjee, P Reddy, ... Circulation: Cardiovascular Interventions, e014143, 2024 | | 2024 |
| CARDIAC FIBROMA AS MANIFESTATION OF NEVOID BASAL CELL CARCINOMA SYNDROME K Chitturi, HG Bonilla, SM Chang Journal of the American College of Cardiology 73 (9S1), 2621-2621, 2019 | | 2019 |
| Cardiotoxicity of immune checkpoint inhibitors in patients with lung cancer KR Chitturi, R Araujo-Gutierrez, ET McLean, J Xu, A Bhimaraj, A Guha, ... Journal of Cardiac Failure 25 (8), S50, 2019 | 1 | 2019 |
| Cardiovascular risks with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and monoclonal antibody therapy KR Chitturi, EA Burns, IN Muhsen, K Anand, BH Trachtenberg Current oncology reports 24 (4), 475-491, 2022 | 7 | 2022 |
| Clinical impact of tricuspid regurgitation on transcatheter edge-to-edge mitral valve repair for mitral regurgitation KR Chitturi, B Bhardwaj, G Murtaza, PR Karuparthi, NN Faza, SS Goel, ... Cardiovascular Revascularization Medicine 41, 1-9, 2022 | 2 | 2022 |
| Coronary microvascular dysfunction and cancer therapy-related cardiovascular toxicity KR Chitturi, S Bhogal, SE Kassaian, I Merdler, W Abusnina, A Chaturvedi, ... Cardiovascular Revascularization Medicine, 2024 | | 2024 |
| Coronary microvascular dysfunction and inflammation: Insights from the Coronary Microvascular Disease Registry I Merdler, KR Chitturi, A Chaturvedi, J Li, M Cellamare, ST Ozturk, ... Cardiovascular Revascularization Medicine, 2024 | | 2024 |
Arvind BhimarajHouston Methodist Hospital在 houstonmethodist.org 的电子邮件经过验证
